5. Lavie CJ, Messerli FH, Milani RV. Beta-blockers as first-line antihypertensive therapy: the crumbling continues. J Am Coll Cardiol. 2009;54:1162–64.
6. Bangalore S, Kumar S, Lobach I. Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and Bayesian random-effects metaanalyses of randomized trials. Circulation. 2011;123:2799–810.
7. Weber MA, Bakris GL, Jamerson K. Avoiding Cardiovascular Events Through COMbination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH). J Am Coll Cardiol. 2010; 56:77-85.
8. Denardo S, Gong Y, Nichols WW. Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy. Am J Med 2010;123:719–26.
9. Cushman WC, Evans GW, Byington RP. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010;362:1575–85.
10. Ong KL, Tso AW, Lam KS. Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension. Hypertension 2008;51:1142–8.
11. Coylewright M, Reckelhoff JF, Ouyang P. Menopause and hypertension: an age-old debate. Hypertension 2008;51:952–9.
12. De la Sierra A, Segura J, Banegas JR. Clinical features of
8295 patients with resistant hypertension classified on the basis of
ambulatory pressure monitoring. Hypertension. 2011;57:898–902.
13 U.S. Census Bureau. Hispanic Population of the United States. Accesible en:
http://www.census.gov/population/www/socdemo/hispanic/hispanic_pop_presentation.html. Último acceso Enero 22, 2011.
14. Epstein M, Calhoun DA. The role of aldosterone in resistant hypertension: implications for pathogenesis and therapy. Curr Hypertens Rep. 2007;9:98–105.
15 Tamura Y, Adachi J, Chiba Y. Primary aldosteronism due to unilateral adrenal microadenoma in an elderly patient: efficacy of selective adrenal venous sampling. Intern Med 2008;47:37–42.
16 Franklin, S S .What Can We Learn From the American Heart Association and American College of Cardiology Expert Consensus Document on Geriatric Hypertension? Clin. Cardiol. 2012; 35: (1) 1–2
17 Funder JW, Carey RM, Fardella C. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008;93:3266–81.
18 McEniery CM, McDonnell BJ, So A. Aortic calcification is associated with aortic stiffness and isolated systolic hypertension in healthy individuals. Hypertension 2009;53:524–31.
19 Lam AY. Assessing medication consultations, hypertension control, awareness, and treatment among elderly Asian community dwellers. Consult Pharm 2008;23:795–803.
20 O'Rourke MF, Hashimoto J. Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol 2007;50:1–13.
21 Verdecchia P, Calvo C, Mockel V. Safety and efficacy of the oral direct renin inhibitor aliskiren in elderly patients with hypertension. Blood Press 2007;16:381–91.
22 Verdecchia P, Staessen JA, Angeli F. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. Lancet 2009;374:525–33.
23 Weber MA. Angiotensin II receptor blockers in older patients. Am J Geriatr Cardiol 2004;13:197–205.
24 Brown MJ, Coltart J, Gunewardena K. Randomized double-blind placebo-controlled study of an angiotensin immunotherapeutic vaccine (PMD3117) in hypertensive subjects. Clin Sci (Lond) 2004;107:167–73.
25 Black HR, Bakris GL, Weber MA. Efficacy and safety of darusentan in patients with resistant hypertension: results from a randomized, double-blind, placebo-controlled dose-ranging study. J Clin Hypertens 2007;9:760–9.
26 Calhoun DA. Low-dose aldosterone blockade as a new treatment paradigm for controlling resistant hypertension. J Clin Hypertens 2007;9:19–24.
27 Mallareddy M, Hanes V, White WB. Drospirenone, a new progestogen, for postmenopausal women with hypertension. Drugs Aging 2007;24:453–66.
28 Welty FK, Lee KS, Lew NS. Effect of soy nuts on blood pressure and lipid levels in hypertensive, prehypertensive, and normotensive postmenopausal women. Arch Intern Med 2007;167:1060–7.